Polypyrimidine-tract-binding protein affects transcription but not translation of mouse hepatitis virus RNA

Virology

Volumn 303, Issue 1, 2002, Pages 58-68

  Choi, Keum S ^a   Huang, Pei Yong ^a,b   Lai, Michael M C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b RIGEL PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; POLYPYRIMIDE TRACT BINDING PROTEIN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL LINE; CELL MUTANT; CONTROLLED STUDY; CYTOPLASM; DIMERIZATION; GENE OVEREXPRESSION; HEPATITIS VIRUS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; RETICULOCYTE LYSATE; RNA TRANSCRIPTION; SYNCYTIUM; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

MURINE HEPATITIS VIRUS; ORYCTOLAGUS CUNICULUS;

EID: 0036920155     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1675     Document Type: Article

References (41)

1. Ali, N., and Siddiqui, A. (1995). Interaction of polypyrimidine tract-binding protein with the 53 noncoding region of the hepatitis C virus RNA genome and its functional requirement in internal initiation of translation. J. Virol. 69, 6367-6375.
2. Back, S. H., Kim, Y. K., Kim, W. J., Cho, S., Oh, H. R., Kim, J. E., and Jang, S. K. (2002). Translation of polioviral mRNA is inhibited by cleavage of polypyrimidine tract-binding proteins executed by polioviral 3C (pro). J. Virol. 76, 2529-2542.
3. Belsham, G. J., and Sonenberg, N. (1996). RNA-protein interactions in regulation of picornavirus RNA translation. Microbiol. Rev. 60, 499-511.
4. Cassetti, M. C., Noah, D. L., Montelione, G. T., and Krug, R. M. (2001). Efficient translation of mRNAs in influenza A virus-infected cells is independent of the viral 53 untranslated region. Virology 289, 180-185.
5. Compton, S. R., Rogers, D. B., Holmes, K. V., Fertsch, D., Remenick, J., and McGowan, J. J. (1987). In vitro replication of mouse hepatitis virus strain A59. J. Virol. 61, 1814-1820.
6. Cote, C. A., Gautreau, D., Denegre, J. M., Kress, T. L., Terry, N. A., and Mowry, K. L. (1999). A Xenopus protein related to hnRNP I has a role in cytoplasmic RNA localization. Mol. Cell 4, 431-437.
7. Furuya, T., and Lai, M. M. C. (1993). Three different cellular proteins bind to complementary sites on the 5′-end-positive and 3′-end-negative-strands of mouse hepatitis virus RNA. J. Virol. 67, 7215-7222.
8. Ghetti, A., Pinol-Roma, S., Michael, W. M., Morandi, C., and Dreyfuss, G. (1992). hnRNP I, the polypyrimidine tract-binding protein: Distinct nuclear localization and association with hnRNAs. Nucleic Acids Res. 20, 3671-3678.
9. Hellen, C. U., Pestova, T. V., Litterst, M., and Wimmer, E. (1994). The cellular polypeptide p57 (pyrimidine tract-binding protein) binds to multiple sites in the poliovirus 5′ nontranslated region. J. Virol. 68, 941-950.
10. Hellen, C. U., Witherell, G. W., Schmid, M., Shin, S. H., Pestova, T. V., Gil, A., and Wimmer, E. (1993). A cytoplasmic 57-kDa protein that is required for translation of picornavirus RNA by internal ribosomal entry is identical to the nuclear pyrimidine tract-binding protein. Proc. Natl. Acad. Sci. USA 90, 7642-7646.
11. Herold, J., and Andino, R. (2001). Poliovirus RNA replication requires genome circularization through a protein-protein bridge. Mol. Cell 7, 581-591.
12. Hirano, N., Fujiwara, K., Hino, S., and Matumoto, M. (1974). Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch. Gesamte Virusforsch. 44, 298-302.
13. Huang, P., and Lai, M. M. C. (1999). Polypyrimidine tract-binding protein binds to the complementary strand of the mouse hepatitis virus 3′ untranslated region, thereby altering RNA conformation. J. Virol. 73, 9110-9116.
14. Huang, P., and Lai, M. M. C. (2001). Heterogeneous nuclear ribonucle-oprotein A1 binds to the 3′-untranslated region and mediates potential 5′-3′-end crosstalks of mouse hepatitis virus RNA. J. Virol. 75, 5009-5017.
15. Kamath, R. V., Leary, D. J., and Huang, S. (2001). Nucleocytoplasmic shuttling of polypyrimidine tract-binding protein is uncoupled from RNA export. Mol. Biol. Cell 12, 3808-3820.
16. Kaminski, A., Hunt, S. L., Patton, J. G., and Jackson, R. J. (1995). Direct evidence that polypyrimidine tract binding protein (PTB) is essential for internal initiation of translation of encephalomyocarditis virus RNA. RNA 1, 924-938.
17. Katja, S., and Hurt, E. (2001). Splicing factor Sub2p is required for nuclear mRNA export through its interaction with Yra1p. Nature 413, 648-652.
18. Kim, Y. K., Hahm, B., and Jang, S. K. (2000). Polypyrimidine tract-binding protein inhibits translation of bip mRNA. J. Mol. Biol. 304, 119-133.
19. Lai, M. M. C., and Cavanagh, D. (1997). The molecular biology of coronaviruses. Adv. Virus Res. 48, 1-100.
20. Li, B., and Yen, T. (2002). Characterization of the nuclear export signal of polypyrimidine tract-binding protein. J. Biol. Chem. 277, 10306-10314.
21. Li, H. P., Huang, P., Park, S., and Lai, M. M. C. (1999). Polypyrimidine tract-binding F protein binds to the leader RNA of mouse hepatitis virus and serves as a regulator of viral transcription. J. Virol. 73, 772-777.
22. Li, H. P., Zhang, X., Duncan, R., Comai, L., and Lai, M. M. C. (1997). Heterogeneous nuclear ribonucleoprotein A1 binds to the transcription-regulatory region of mouse hepatitis virus RNA. Proc. Natl. Acad. Sci. USA 94, 9544-9549.
23. Liao, C.-L., and Lai, M. M. C. (1994). Requirement of the 5′-end genomic sequence as an upstream cis-acting element for coronavirus sub-genomic mRNA transcription. J. Virol. 68, 4727-4737.
24. Liao, C. L., Zhang, X., and Lai, M. M. C. (1995). Coronavirus defective-interfering RNA as an expression vector: The generation of a pseudorecombinant mouse hepatitis virus expressing hemagglutinin-esterase. Virology 208, 319-327.
25. Lin, Y. J., Zhang, X., Wu, R. C., and Lai, M. M. C. (1996). The 3′ untranslated region of coronavirus RNA is required for subgenomic mRNA transcription from a defective interfering RNA. J. Virol. 70, 7236-7240.
26. Makino, S., Joo, M., and Makino, J. K. (1991). A system for study of coronavirus mRNA synthesis: A regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion. J. Virol. 65, 6031-6041.
27. Makino, S., Shieh, C. K., Soe, L. H., Baker, S. C., and Lai, M. M. C. (1988). Primary structure and translation of a defective interfering RNA of murine coronavirus. Virology 166, 550-560.
28. Moreira, A., Takagaki, Y., Brackenridge, S., Wollerton, M., Manley, J. L., and Proudfoot, N. J. (1998). The upstream sequence element of the C2 complement poly(A) signal activates mRNA 3′ end formation by two distinct mechanisms. Genes Dev. 12, 2522-2534.
29. Nanda, S. K., and Leibowitz, J. L. (2001). Mitochondrial aconitase binds to the 3′ untranslated region of the mouse hepatitis virus genome. J. Virol. 75, 3352-3362.
30. Oh, Y. L., Hahm, B., Kim, Y. K., Lee, H. K., Lee, J. W., Song, O., Tsukiyama-Kohara, K., Kohara, M., Nomoto, A., and Jang, S. K. (1998). Determination of functional domains in polypyrimidine-tract-binding protein. Biochem. J. 331, 169-175.
31. Perez, I., Mcafee, J. G., and Patton, J. G. (1997). Multiple RRMs contribute to RNA binding specificity and affinity for polypyrimidine tract binding protein. Biochemistry 36, 11881-11890.
32. Schnapp, B. J. (1999). A glimpse of the machinery. Curr. Biol. 9, R725-727.
33. Shen, X., and Masters, P. S. (2001). Evaluation of the role of heterogeneous nuclear ribonucleoprotein A1 as a host factor in murine coronavirus discontinuous transcription and genome replication. Proc. Natl. Acad. Sci. USA 98, 2717-2722.
34. Shi, S. T., Huang, P., Li, H. P., and Lai, M. M. C. (2000). Heterogeneous nuclear ribonucleoprotein A1 regulates RNA synthesis of a cytoplasmic virus. EMBO J. 19, 4701-4711.
35. Spagnolo, J. F., and Hogue, B. G. (2000). Host protein interactions with the 3′ end of bovine coronavirus RNA and the requirement of the poly(A) tail for coronavirus defective genome replication. J. Virol. 74, 5053-5065.
36. Stohlman, S. A., Baric, R. S., Nelson, G. N., Soe, L. H., Welter, L. M., and Deans, R. J. (1988). Specific interaction between coronavirus leader RNA and nucleocapsid protein. J. Virol. 62, 4288-4295.
37. Tahara, S. M., Dietlin, T. A., Nelson, G. W., Stohlman, S. A., and Manno, D. J. (1998). Mouse hepatitis virus nucleocapsid protein as a translational effector of viral mRNAs. Adv. Exp. Med. Biol. 440, 313-318.
38. Wagner, E. J., and Garcia-Blanco, M. A. (2001). Polypyrimidine tract binding protein antagonizes exon definition. Mol. Cell. Biol. 21, 3281-3288.
39. Wang, Y., and Zhang, X. (1999). The nucleocapsid protein of coronavirus mouse hepatitis virus interacts with the cellular heterogeneous nuclear ribonucleoprotein A1 in vitro and in vivo. Virology 265, 96-109.
40. Zang, W. Q., Li, B., Huang, P. Y., Lai, M. M. C., and Yen, T. S. (2001). Role of polypyrimidine tract binding protein in the function of the hepatitis B virus posttranscriptional regulatory element. J. Virol. 75, 10779-10786.
41. Zhang, X., and Lai, M. M. C. (1995). Interactions between the cytoplasmic proteins and the intergenic (promoter) sequence of mouse hepatitis virus RNA: Correlation with the amounts of subgenomic mRNA transcribed. J. Virol. 69, 1637-1644.